Magid H. Amer

1.5k total citations
28 papers, 1.2k citations indexed

About

Magid H. Amer is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Magid H. Amer has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Pathology and Forensic Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Magid H. Amer's work include Head and Neck Cancer Studies (4 papers), Global Cancer Incidence and Screening (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Magid H. Amer is often cited by papers focused on Head and Neck Cancer Studies (4 papers), Global Cancer Incidence and Screening (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Magid H. Amer collaborates with scholars based in Saudi Arabia, United States and Egypt. Magid H. Amer's co-authors include Muhyi Al‐Sarraf, Vainutis K. Vaitkevicius, Laurence H. Baker, John T. Godwin, Rajeh Sabbah, V. K. Vaitkevicius, Adnan El‐Yazigi, Mohammed A. Hannan, Mohamed E. Mohamed and Mohammed A. Hannan and has published in prestigious journals such as Gastroenterology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Magid H. Amer

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magid H. Amer Saudi Arabia 15 495 449 277 236 203 28 1.2k
R. Sealy South Africa 18 399 0.8× 273 0.6× 149 0.5× 97 0.4× 249 1.2× 49 1.3k
Paola Casieri Italy 19 624 1.3× 497 1.1× 389 1.4× 255 1.1× 346 1.7× 43 1.5k
Jay Wasman United States 20 446 0.9× 245 0.5× 254 0.9× 113 0.5× 295 1.5× 63 1.3k
Eble Jn United States 5 371 0.7× 434 1.0× 439 1.6× 186 0.8× 417 2.1× 8 1.4k
Karl Götte Germany 20 425 0.9× 257 0.6× 340 1.2× 56 0.2× 238 1.2× 44 1.1k
K.K. Ang United States 15 580 1.2× 508 1.1× 302 1.1× 65 0.3× 390 1.9× 59 1.4k
T Elhakim Canada 10 593 1.2× 308 0.7× 106 0.4× 147 0.6× 256 1.3× 14 947
Gwi Eon Kim South Korea 23 814 1.6× 364 0.8× 159 0.6× 461 2.0× 545 2.7× 64 1.7k
William H. Liggett United States 10 588 1.2× 411 0.9× 522 1.9× 67 0.3× 118 0.6× 16 1.2k
M. Housset France 17 345 0.7× 238 0.5× 170 0.6× 129 0.5× 514 2.5× 61 1.2k

Countries citing papers authored by Magid H. Amer

Since Specialization
Citations

This map shows the geographic impact of Magid H. Amer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magid H. Amer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magid H. Amer more than expected).

Fields of papers citing papers by Magid H. Amer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magid H. Amer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magid H. Amer. The network helps show where Magid H. Amer may publish in the future.

Co-authorship network of co-authors of Magid H. Amer

This figure shows the co-authorship network connecting the top 25 collaborators of Magid H. Amer. A scholar is included among the top collaborators of Magid H. Amer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magid H. Amer. Magid H. Amer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amer, Magid H.. (2014). Multiple neoplasms, single primaries, and patient survival. Cancer Management and Research. 6. 119–119. 80 indexed citations
2.
Amer, Magid H.. (2014). Genetic factors and breast cancer laterality. Cancer Management and Research. 191–191. 36 indexed citations
3.
Amer, Magid H.. (2013). Cancer-associated thrombosis: clinical presentation and survival. Cancer Management and Research. 5. 165–165. 28 indexed citations
4.
Bakri, Younes N., et al.. (1998). Carcinoma of the uterine cervix in Saudi Arabia: experience in the management of 164 patients with stage-I & -II disease. International Journal of Radiation Oncology*Biology*Physics. 42(1). 91–100. 4 indexed citations
5.
El‐Yazigi, Adnan, Osman Alfurayh, & Magid H. Amer. (1995). Pharmacokinetics of Carboplatin in a Patient with Cervical Cancer with Ureteric Obstruction Before, During, and After Hemodialysis. The Journal of Clinical Pharmacology. 35(10). 1003–1007. 2 indexed citations
6.
Amer, Magid H., et al.. (1994). Gastrointestinal lymphoma in adults: Clinical features and management of 300 cases. Gastroenterology. 106(4). 846–858. 113 indexed citations
7.
Amer, Magid H., Adnan El‐Yazigi, Mohammed A. Hannan, & Mohamed E. Mohamed. (1990). Water Contamination and Esophageal Cancer at Gassim Region, Saudi Arabia. Gastroenterology. 98(5). 1141–1147. 25 indexed citations
8.
Amer, Magid H.. (1990). Cancer Control in the Arab World. Annals of Saudi Medicine. 10(4). 367–368. 1 indexed citations
9.
Quick, Cedric A., Magid H. Amer, Mohammed Ashraf Ali, et al.. (1990). Nasopharyngeal Carcinoma in Saudi Arabia: Selected Clinical and Epidemiological Aspects. Annals of Saudi Medicine. 10(2). 171–175. 5 indexed citations
10.
El‐Yazigi, Adnan, et al.. (1989). Pharmacokinetics of Platinum in Cancer Patients Treated with Carboplatin in Combination with High-Dose Methotrexate. Pharmaceutical Research. 6(6). 492–496. 4 indexed citations
11.
Amer, Magid H.. (1987). The Need for a National Cancer Registry in Saudi Arabia. Annals of Saudi Medicine. 7(4). 263–264. 5 indexed citations
12.
Amer, Magid H., et al.. (1986). Pharmacokinetics of methotrexate and its 7‐OH metabolite in cancer patients treated with different high‐methotrexate dosage regimens. International Journal of Cancer. 38(6). 795–800. 6 indexed citations
13.
Amer, Magid H., et al.. (1986). Pattern of cancer in saudi arabs referred to king faisal specialist hospital. Cancer. 58(5). 1172–1178. 76 indexed citations
14.
Amer, Magid H., et al.. (1985). Shamma Usage and Oral Cancer in Saudi Arabia. Annals of Saudi Medicine. 5(3). 135–140. 30 indexed citations
15.
Hannan, Mohammed A., et al.. (1984). Study of ultraviolet radiation and genotoxic effects of natural sunlight in relation to skin cancer in Saudi Arabia.. PubMed. 44(5). 2192–7. 23 indexed citations
16.
Amer, Magid H.. (1982). Chemotherapy and pattern of metastases in breast cancer patients. Journal of Surgical Oncology. 19(2). 101–105. 38 indexed citations
17.
Amer, Magid H., et al.. (1982). Bullous Pemphigoid after Chemotherapy for Choriocarcinoma. International Journal of Dermatology. 21(1). 32–36. 7 indexed citations
19.
Amer, Magid H., Muhyi Al‐Sarraf, & Vainutis K. Vaitkevicius. (1979). Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancer. Cancer. 43(6). 2202–2206. 94 indexed citations
20.
Amer, Magid H., Muhyi Al‐Sarraf, Laurence H. Baker, & Vainutis K. Vaitkevicius. (1978). Malignant melanoma and central nervous system metastases.Incidence, diagnosis, treatment and survival. Cancer. 42(2). 660–668. 316 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026